The regulatory role of E2F1 in prostate cancer
10.16438/j.0513-4870.2020-1813
- VernacularTitle:E2F1在前列腺癌中的调控作用
- Author:
Ming-yi ZHANG
;
Ming JI
;
Xiao-guang CHEN
- Publication Type:Research Article
- Keywords:
prostate cancer;
E2F1;
retinoblastoma;
androgen receptor
- From:
Acta Pharmaceutica Sinica
2021;56(3):654-660
- CountryChina
- Language:Chinese
-
Abstract:
E2F transcription factor 1 (E2F1) is a major member of the E2F transcription factor family and participates in a wide range of physiological regulatory processes, such as cell cycle, survival, apoptosis, and metabolism. It is proved that the activity of E2F1 is related to the G1/S phase regulation of the cell cycle dependent on tumor suppressor retinoblastoma protein (RB). Recent studies have shown that E2F1 is highly expressed in prostate cancer cells, manifested as an oncogene, and its expression level is closely related to the occurrence, development, and poor clinical prognosis of prostate cancer. Androgen receptor (AR) is the main driving factor for the growth and progression of prostate cancer, and the changes of AR pathway play a key role in the pathological progression of prostate cancer. This article provide a systematic and comprehensive summary on recently published articles to review the role of the E2F1 pathway in prostate cancer.
